Background The impact of pneumococcal conjugate vaccines (PCVs) on the burden of
invasive pneumococcal disease (IPD) and serotype distribution was examined across age …

Introduction This study estimates the annual population-level impact of 13-valent
pneumococcal conjugate vaccine (PCV13) infant national immunization programs (NIPs) on …

Following the introduction of pneumococcal conjugate vaccines (PCVs), the rate of invasive
pneumococcal disease (IPD) declined, however, IPDs replaced by serotypes that are not …

Background There is a paucity of data on the burden of the full spectrum of community-
acquired pneumonia (CAP) and acute otitis media (AOM) from outpatient and inpatient …

Background Invasive pneumococcal disease (IPD) burden, evaluated in Canada using
reported confirmed cases in surveillance systems, is likely underestimated due to …

Pneumococcal disease is one of the most common and severe vaccine-preventable
diseases (VPDs). Despite the advances in antimicrobial treatment, pneumococcal disease …

Streptococcus pneumoniae forma parte de la flora bacteriana normal de la mucosa nasal y
faríngea, coloniza principalmente la nasofaringe y provoca que esta portación preceda a la …

Introduction: This study estimates the annual population-level impact of 13-valent
pneumococcal conjugate vaccine (PCV13) infant national immunization programs (NIPs) on …

Of over 100 serotypes of Streptococcus pneumoniae, only 7 were included in the first
pneumococcal conjugate vaccine (PCV). While PCV reduced the disease incidence, in part …

Adult community-acquired pneumonia remains a leading cause of global disease and death
as well as a major public health concern. A number of pathogens can cause the disease …